• SENSEX 74,227.08
    1,089.18 (+1.49%)
  • BANKNIFTY 50,511.00
    650.90 (+1.31%)
  • Tata Motors
    606.40 1,179.05(%)
  • Reliance Industr
    1,196.80 1,608.95(%)
  • HDFC Bank
    1,782.00 1,880.00(%)
  • TCS
    3,348.90 4,585.90(%)
  • UltraTech Cem.
    11,538.00 12,143.90(%)
  • Eternal Ltd
    219.15 304.50(%)
  • Larsen & Toubro
    3,194.25 3,963.00(%)
  • Mazagon Dock
    2,446.00 2,929.98(%)
  • Hind.Aeronautics
    4,137.65 5,675.00(%)
  • Bharat Electron
    287.85 340.35(%)
  • Infosys
    1,456.50 2,006.80(%)
  • Nippon ETF Liq.
    1,000.01 1,005.00(%)
  • Trent
    4,963.25 8,345.85(%)
  • Siemens
    2,750.00 2,271.44(%)
  • Bajaj Finance
    8,873.05 9,258.95(%)
  • ITC
    415.65 500.01(%)
  • Vodafone Idea
    7.14 6.60(%)
  • Suzlon Energy
    54.20 86.04(%)
  • Kalyan Jewellers
    505.30 794.60(%)
  • Tata Steel
    136.25 184.60(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Solara Active Pharma Sciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 70281.0
  • ISIN : INE624Z01016
509.35 14 (2.82%)
  • As on 08 Apr 2025 (EOD)

  • Today’s Low

    495.10

  • Today’s High

    515.95

  • Open

    495.10

  • Perv Close

    495.40

  • 52W Low

    361.50

  • 52W High

    882.80

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    1,836.42

  • Div & Yield %

    0.00

  • Book Value(₹)

    301.39

  • Debt-Equity Ratio

    2.82

  • AGM Date

    08-Apr-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.83

  • Mar.Cap (₹Cr.)

    1,836.42

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    36.05

  • BV (₹)

    301.40

  • Sales( ₹ in Cr.)

    1,288.92

  • NP (in Cr.)

    -408.03

  • NP Var(%)

    -1775.0

  • Div%

    0.0

  • CPS (₹)

    -84.60

  • EPS (₹)

    -113.20

  • Traded Value (₹ in Lakhs)

    1,837.33

  • 52 Week High

    882.80

  • 52 Week Low

    361.50

  • Price BSE

    510.0

  • Price NSE

    509.00

  • Market Capital( in Cr.)

    1,837.33

  • P/C Ratio

    -6.00

  • P/E Ratio

    -4.50

  • Price Vs.BV

    -113.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 1,288.92 1,443.81 1,268.34 1,616.88 1,321.75 1,386.68
Excise Duty 1,226.47 1,374.01 1,207.44 1,563.85 1,250.83 1,291.76
Net Sales 1,288.92 1,443.81 1,268.34 1,616.88 1,321.75 1,386.68
Other Income 5.37 22.14 18.76 28.41 27.51 12.03
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 -5.77
Total Income 1,294.29 1,465.95 1,287.10 1,645.29 1,349.26 1,398.71
EXPENDITURE :
Raw Materials 1,226.47 1,374.01 1,207.44 1,563.85 1,250.83 1,291.76
Power & Fuel Cost 1,226.47 1,374.01 1,207.44 1,563.85 1,250.83 1,291.76
Employee Cost 243.92 228.05 234.20 227.63 202.24 183.98
Other Manufacturing Expenses 32.77 26.68 31.94 26.83 22.74 40.70
Selling & Administrative Expenses 70.40 67.50 76.39 76.07 74.19 64.70
Miscellaneous Expenses 32.77 26.68 31.94 26.83 22.74 40.70
Less : Pre-operative Expenses Capitalised :
Total Expenditure 1,592.98 1,510.73 1,375.27 1,424.33 1,236.77 1,330.35
Operating Profit 231.87 198.71 191.57 176.61 167.18 170.93
Interest 105.97 90.06 75.27 84.47 77.88 82.42
Gross Profit -488.33 -44.78 -91.66 220.96 112.49 68.36
Depreciation 103.03 110.90 112.01 108.31 93.67 82.79
Profit Before Tax -488.33 -44.78 -91.66 220.96 112.49 68.36
Tax 0.00 -0.11 0.00 38.64 20.69 15.96
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 78.54 -22.46 -33.10 -38.64 -20.69 -13.95
Reported Net Profit -566.87 -22.21 -58.56 220.96 112.49 66.35
Extraordinary Items -488.33 -44.78 -91.66 220.96 112.49 68.36
Adjusted Net Profit -566.87 -22.21 -58.56 220.96 112.49 66.35
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -5.77
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 -9.92
Statutory Appropriations 0.00 10.80 0.00 25.14 5.37 12.89
P & L Balance carried down -566.87 -22.21 -58.56 220.96 112.49 66.35
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 30.00 0.00 70.00 20.00 50.00
Dividend Per Share(Rs) 0.00 3.00 0.00 7.00 2.00 5.00
Earnings Per Share-Unit Curr -157.48 -6.17 -16.29 68.86 43.47 21.42
Book Value 0.00 10.80 0.00 25.14 5.37 12.89
Book Value(Adj)-Unit Curr 0.00 10.80 0.00 25.14 5.37 12.89

Shareholding Pattern

  • Promoter Group

    37.23%

  • Public Share Holding

    62.77%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 14,487,903 30.15 14,487,903 9
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,401,417 7.08 3,401,417 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 17,889,320 37.23 17,889,320 20
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 1,354 0.00 1,354 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,356 0.00 1,356 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,049,769 14.67 7,049,769 62
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 616,120 1.28 616,120 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 915,817 1.91 915,817 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 8,584,416 17.86 8,584,416 75
2] Non Institution
Bodies Corporate 4,180,150 8.70 4,179,711 528
Clearing Members 1,098 0.00 1,098 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 502,712 1.05 501,396 1,679
Foreign Non Institution Other 1,382,899 2.88 1,382,899 2
Hindu Undivided Families 812,760 1.69 812,667 1,622
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,160,978 4.50 2,160,978 43
Individuals holding nominal share capital up to Rs. 1 lakh 8,374,632 17.43 8,351,768 79,106
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 3,956 0.01 3,956 3
Others 67,906 0.14 67,906 4
Sub Total 21,579,286 44.91 21,554,574 83,053
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 48,053,022 100.00 48,028,310 83,148

Company Background

Solara Active Pharma Sciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Solara Active Pharma Sciences Ltd
  • BSE Code : 70281.0
  • ISIN : INE624Z01016

  • Incorporation Year

    2017

  • Registered Office

    201 Devavrata Sector 17 Vashi
    Navi Mumbai, Mumbai,
    Maharashtra-400703

  • Telephone

    91-22-27892924

  • FAX

    91-22-27892942

  • Chairman

    RAJAGOPALAN RAMAKRISHNAN

  • Managing Director

    Sandeep Rao

  • Company Secretary

    S Murali Krishna

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    1ST Floor No 1,Club House Road
    Mumbai - Chennai - 600002

Solara Active Pharma Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Solara Active 509.60 1,294.29 1,288.92 -7.27 0.00
Abbott India 29,413.45 6,097.18 5,848.91 46.84 44.71
Astrazeneca Phar 8,061.90 1,330.33 1,295.53 207.83 33.26
P & G Health Ltd 5,104.95 1,166.89 1,151.26 35.82 39.76
Glaxosmi. Pharma 2,728.95 3,530.73 3,407.25 54.26 44.44
Cipla 1,433.45 17,645.00 16,574.34 24.57 20.10
Amrutanjan Healt 629.40 437.58 421.23 36.89 20.84
Fermenta Biotec. 271.05 315.24 307.09 25.69 4.10
Guj. Themis Bio. 253.25 174.19 169.82 52.43 44.82
Bliss GVS Pharma 120.15 638.96 605.46 27.49 11.19
Ambalal Sarabhai 36.60 11.70 3.81 15.64 1.92